The pro forma equity value of the portion of the combined company attributable to Tevogen Bio Inc (“Tevogen Bio”) stockholders is an expected $1.2 billion. Tevogen Bio is an advanced-stage specialty ...
New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced ...
Ask most people the meaning and significance of the words “semper paratus,” and you likely will get nothing more than a blank stare in return. For those who don’t know, “semper paratus” is Latin for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results